Pain News and Research

Latest Pain News and Research

One-third of RA patients discontinue therapy within the first year of treatment

Data presented at EULAR 2013, the Annual Congress of the European League Against Rheumatism, show that up to one-third of rheumatoid arthritis patients discontinue or change therapy within the first year of treatment.

13 Jun 2013

Pregnancy carried to childbirth increases risk of ACPA-negative RA

Epidemiological data presented today at EULAR 2013, the Annual Congress of the European League Against Rheumatism, demonstrate that pregnancy carried to childbirth (parity) increases the risk of ACPA-negative rheumatoid arthritis.

13 Jun 2013

Study: Depression indicators are stronger predictors of work disability in early arthritis

Data presented today at EULAR 2013, the Annual Congress of the European League Against Rheumatism, demonstrate that indicators of depression are stronger predictors of work disability in early arthritis than disease activity or response to therapy.

13 Jun 2013

University of Oxford researchers receive grant to study genes that contribute to ankylosing spondylitis

A team at the University of Oxford has received a grant of £160,000 from Arthritis Research UK to study the function of the genes which contribute to people developing a painful inflammatory back condition called ankylosing spondylitis.

13 Jun 2013

Study on the development of internet-based physical activity intervention presented at EULAR 2013

Results of the first study involving RA patients in the development of an internet-based physical activity intervention were presented at EULAR 2013, the Annual Congress of the European League Against Rheumatism.

13 Jun 2013

New study shows treatment with brodalumab demonstrates clinical response in subjects with PsA

A new study presented today at EULAR 2013, the Annual Congress of the European League Against Rheumatism, shows that treatment with brodalumab demonstrates significant clinical response and an acceptable safety profile in subjects with psoriatic arthritis.

13 Jun 2013

Celgene announces positive results from first phase III study of apremilast in psoriatic arthritis

Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation, today announced 52-week results from PALACE 1, the Company's first phase III study in psoriatic arthritis at the European Congress of Rheumatology annual meeting in Madrid, Spain.

12 Jun 2013

Researchers to launch Phase II clinical trial to investigate potential new therapy for sickle cell anemia

Seeking to improve the lives of sickle cell anemia sufferers around the world, researchers from the La Jolla Institute for Allergy and Immunology, the Dana-Farber/Children's Hospital Cancer Center in Boston and the BloodCenter of Wisconsin in Milwaukee and others are preparing to launch Phase II of a clinical trial to investigate a potential new therapy for reducing the disorder's severest symptoms.

12 Jun 2013

Home treatment improves chronic constipation in children

Home treatment with a simple, battery-operated system that applies four sticky electrode patches to the mid-section allowed a group of children with the most difficult-to-treat, possibly congenital, constipation to reduce soiling and improve elimination, according to results presented today at the 11th World Congress of the International Neuromodulation Society.

12 Jun 2013

Neuromodulators provide guidelines for implantation of "digital drugs" to manage chronic pain

Neuromodulators have joined together in the Neuromodulation Appropriateness Consensus Committee (NACC) to provide the first coordinated set of recommendations about patient selection and appropriateness for implantation of "digital drugs" to manage chronic pain.

12 Jun 2013

Research: GPs could more accurately predict outcome of patients with musculoskeletal conditions

GPs could more accurately predict the likely progression of disease in patients with musculoskeletal conditions by asking them a simple set of generic questions during their very first consultation, new research funded by Arthritis Research UK has shown.

12 Jun 2013

State highlights: Medi-Cal rate cuts loom; Latin American docs help meet need

In an office decorated with Chinese art and diagrams of body parts, Dr. George Ma cares for more than 4,000 patients. Nearly three-quarters are covered by Medi-Cal, the state's public insurance program for low-income Californians, and Ma said he receives $10 a month to treat most of them (Gorman and York, 6/10).

12 Jun 2013

Insider probe over Medicare rate decision hits Congress

News outlets report on developments in the story of alleged insider trading after a Medicare rate decision.

12 Jun 2013

Two studies shed light on joint replacement outcomes in rheumatoid arthritis patients

Two new studies by researchers at Hospital for Special Surgery have shed light on joint replacement outcomes in patients with rheumatoid arthritis. One study overturns the common belief that RA patients have worse outcomes after a total knee replacement than patients who undergo the operation for osteoarthritis. The other study demonstrates that RA patients who undergo a total hip replacement were as likely to have significant improvements in function and pain as patients with osteoarthritis, even though they did not do as well.

12 Jun 2013

CLAAD urges FDA to implement Obama administration's policy on safer opioid medications

The Center for Lawful Access and Abuse Deterrence joined in signing a Citizen Petition filed today urging the Food and Drug Administration to fully implement the Obama administration's policy supporting a market transition to safer opioid medications.

11 Jun 2013

Brandeis University professor receives 2013 Neuroscience Prize for pioneering contributions in neural circuits

Eve Marder, PhD, a professor of neuroscience at Brandeis University, is the recipient of the 2013 Neuroscience Prize of The Gruber Foundation. Marder is being honored with this prestigious international award for her pioneering contributions to the understanding of neural circuits, particularly how the properties and dynamics of neural circuits give rise to specific behaviors.

11 Jun 2013

MHN, Auxilium Pharmaceuticals launch new health awareness program on Peyronie's disease

Men's Health Network and Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, have announced the launch of a new health awareness program called "Ask About the Curve" to provide information about Peyronie's disease and to help empower men to have meaningful discussions about their condition with their partner and their healthcare provider.

11 Jun 2013

ECG in your mobile!

A research scientist working at VTT Technical Research Centre of Finland has developed a user-friendly smart phone application that allows consumers to take an electrocardiogram (ECG) in the comfort of their own homes.

11 Jun 2013

First Edition: June 11, 2013

Today's headlines include coverage of the Obama administration's decision to drop the fight to keep age restrictions in place for Plan B emergency contraceptive pill sales.

11 Jun 2013

Vertical Pharmaceuticals, Nautilus Neurosciences sign co-promotion agreement for Lorzone

Vertical Pharmaceuticals, Inc. today announced that Vertical and Nautilus Neurosciences have entered into a co-promotion agreement for Lorzone (chlorzoxazone tablets, USP), a safe, effective, and fast-acting muscle relaxant that is not associated with significant sedation or drowsiness.

11 Jun 2013

Pain News and Research

Latest Pain News and Research

One-third of RA patients discontinue therapy within the first year of treatment

Pregnancy carried to childbirth increases risk of ACPA-negative RA

Study: Depression indicators are stronger predictors of work disability in early arthritis

University of Oxford researchers receive grant to study genes that contribute to ankylosing spondylitis

Study on the development of internet-based physical activity intervention presented at EULAR 2013

New study shows treatment with brodalumab demonstrates clinical response in subjects with PsA

Celgene announces positive results from first phase III study of apremilast in psoriatic arthritis

Researchers to launch Phase II clinical trial to investigate potential new therapy for sickle cell anemia

Home treatment improves chronic constipation in children

Neuromodulators provide guidelines for implantation of "digital drugs" to manage chronic pain

Research: GPs could more accurately predict outcome of patients with musculoskeletal conditions

State highlights: Medi-Cal rate cuts loom; Latin American docs help meet need

Insider probe over Medicare rate decision hits Congress

Two studies shed light on joint replacement outcomes in rheumatoid arthritis patients

CLAAD urges FDA to implement Obama administration's policy on safer opioid medications

Brandeis University professor receives 2013 Neuroscience Prize for pioneering contributions in neural circuits

MHN, Auxilium Pharmaceuticals launch new health awareness program on Peyronie's disease

ECG in your mobile!

First Edition: June 11, 2013

Vertical Pharmaceuticals, Nautilus Neurosciences sign co-promotion agreement for Lorzone

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Pain News and Research

Latest Pain News and Research

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Newsletters you may be interested in